{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:54:31Z","timestamp":1793141671351,"version":"4.5.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jhepr.2023.100911","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T11:35:06Z","timestamp":1695468906000},"page":"100911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Cardiomyopathy in cirrhosis: From pathophysiology to clinical care"],"prefix":"10.1016","volume":"6","author":[{"given":"Hongqun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6210-7669","authenticated-orcid":false,"given":"Jwan A.","family":"Naser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8087-1150","authenticated-orcid":false,"given":"Grace","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4431-272X","authenticated-orcid":false,"given":"Samuel S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100911_bib1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.30875","article-title":"Redefining cirrhotic cardiomyopathy for the modern era","volume":"71","author":"Izzy","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100911_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11894-020-00783-1","article-title":"Cirrhotic cardiomyopathy","volume":"22","author":"Yoon","year":"2020","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jhepr.2023.100911_bib3","doi-asserted-by":"crossref","first-page":"849253","DOI":"10.3389\/fnetp.2022.849253","article-title":"Pathogenic mechanisms underlying cirrhotic cardiomyopathy","volume":"2","author":"Liu","year":"2022","journal-title":"Front Netw Physiol"},{"issue":"9","key":"10.1016\/j.jhepr.2023.100911_bib4","article-title":"Innate Immune Cells in Pressure Overload-Induced Cardiac Hypertrophy and Remodeling","volume":"23","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jhepr.2023.100911_bib5","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.01.021","article-title":"Blunted cardiac response to hemorrhage in cirrhotic rats is mediated by local macrophage-released endocannabinoids","volume":"62","author":"Gaskari","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100911_bib6","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/europace\/eux271","article-title":"Acute administration of tumour necrosis factor-alpha induces spontaneous calcium release via the reactive oxygen species pathway in atrial myocytes","volume":"20","author":"Zuo","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.jhepr.2023.100911_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/CCM.0b013e3181b4a854","article-title":"Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes","volume":"38","author":"Kao","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jhepr.2023.100911_bib8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/1440-1681.12585","article-title":"Role of tumour necrosis factor-a in the regulation of T-type calcium channel current in HL-1 cells","volume":"43","author":"Rao","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.jhepr.2023.100911_bib9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.arcmed.2020.11.004","article-title":"Myocardial dysfunction in cirrhotic cardiomyopathy is associated with alterations of phospholamban phosphorylation and IL-6 levels","volume":"52","author":"Gregolin","year":"2021","journal-title":"Arch Med Res"},{"key":"10.1016\/j.jhepr.2023.100911_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.1840120306","article-title":"Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats","volume":"12","author":"Lee","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100911_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s12265-021-10161-5","article-title":"Role of anti-beta-1-adrenergic receptor antibodies in cardiac dysfunction in patients with cirrhotic cardiomyopathy","volume":"15","author":"Ma","year":"2022","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.jhepr.2023.100911_bib12","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jhep.2018.01.006","article-title":"Cirrhotic cardiomyopathy","volume":"69","author":"Moller","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100911_bib13","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJM196211222672105","article-title":"Studies of the cardiovascular system in the hypotension of liver failure","volume":"267","author":"Mashford","year":"1962","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100911_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00424-019-02272-5","article-title":"Titin mutations and muscle disease","volume":"471","author":"Kellermayer","year":"2019","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jhepr.2023.100911_bib15","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3389\/fphys.2019.01436","article-title":"The giant protein titin\u2019s role in cardiomyopathy: genetic, transcriptional, and post-translational modifications of TTN and their contribution to cardiac disease","volume":"10","author":"Tharp","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.jhepr.2023.100911_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.CIR.0000135591.37759.AF","article-title":"Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy","volume":"110","author":"Nagueh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jhepr.2023.100911_bib17","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2011.02.030","article-title":"Role of cardiac myofilament proteins titin and collagen in the pathogenesis of diastolic dysfunction in cirrhotic rats","volume":"55","author":"Glenn","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100911_bib18","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1111\/liv.14599","article-title":"Impaired myosin isoform shift and calcium transients contribute to cellular pathogenesis of rat cirrhotic cardiomyopathy","volume":"40","author":"Honar","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100911_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MOG.0000000000000733","article-title":"Advances in cirrhotic cardiomyopathy","volume":"37","author":"Liu","year":"2021","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100911_bib20","first-page":"G87","article-title":"Membrane physical properties determine cardiac beta-adrenergic receptor function in cirrhotic rats","volume":"267","author":"Ma","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhepr.2023.100911_bib21","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0168-8278(97)80259-0","article-title":"Effects of altered cardiac membrane fluidity on beta-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy","volume":"26","author":"Ma","year":"1997","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100911_bib22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3350\/cmh.2021.0141","article-title":"Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats","volume":"28","author":"Yoon","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100911_bib23","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/lt.26000","article-title":"Cirrhotic cardiomyopathy predicts posttransplant cardiovascular disease: revelations of the new diagnostic criteria","volume":"27","author":"Izzy","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhepr.2023.100911_bib24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5114\/ceh.2021.108708","article-title":"Prevalence and prognostic value of cirrhotic cardiomyopathy as defined according to the proposed new classification","volume":"7","author":"Cesari","year":"2021","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.jhepr.2023.100911_bib25","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.1007\/s10620-022-07412-z","article-title":"Impact of cirrhotic cardiomyopathy diagnosed according to different criteria on patients with cirrhosis awaiting liver transplantation: a retrospective cohort study","volume":"67","author":"Singh","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2023.100911_bib26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.15403\/jgld-3137","article-title":"Cirrhotic cardiomyopathy in the era of liver transplantation: time for precise stepwise evaluation","volume":"29","author":"Rimbas","year":"2020","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100911_bib27","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.30913","article-title":"Appraisal of cardiac ejection fraction with liver disease severity: implication in post-liver transplantation mortality","volume":"71","author":"Kwon","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100911_bib28","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/eurheartj\/ehv529","article-title":"Myocardial strain imaging: how useful is it in clinical decision making?","volume":"37","author":"Smiseth","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jhepr.2023.100911_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ihj.2012.12.009","article-title":"Early impairment of left ventricular function in patients with systemic hypertension: new insights with 2-dimensional speckle tracking echocardiography","volume":"65","author":"Sengupta","year":"2013","journal-title":"Indian Heart J"},{"key":"10.1016\/j.jhepr.2023.100911_bib30","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation\/American heart association task force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhepr.2023.100911_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/19932820.2017.1283162","article-title":"Cirrhotic cardiomyopathy: is there any correlation between the stage of cardiac impairment and the severity of liver disease?","volume":"12","author":"Hammami","year":"2017","journal-title":"Libyan J Med"},{"key":"10.1016\/j.jhepr.2023.100911_bib32","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/apt.14934","article-title":"Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study","volume":"48","author":"Novo","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2023.100911_bib33","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/liv.12187","article-title":"Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study","volume":"33","author":"Sampaio","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100911_bib34","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ultrasmedbio.2017.11.013","article-title":"New definition criteria of myocardial dysfunction in patients with liver cirrhosis: a speckle tracking and tissue Doppler imaging study","volume":"44","author":"Rimbas","year":"2018","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.jhepr.2023.100911_bib35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.15171\/jcvtr.2019.22","article-title":"Reduced myocardial reserve in cirrhotic patients: an evaluation by dobutamine stress speckle tracking and tissue Doppler imaging (TDI) echocardiography","volume":"11","author":"Zamirian","year":"2019","journal-title":"J Cardiovasc Thorac Res"},{"key":"10.1016\/j.jhepr.2023.100911_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13613-018-0376-8","article-title":"Use of speckle-tracking strain in preload-dependent patients, need for cautious interpretation","volume":"8","author":"Nafati","year":"2018","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jhepr.2023.100911_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082616","article-title":"Global longitudinal strain at rest as an independent predictor of mortality in liver transplant candidates: a retrospective clinical study","volume":"9","author":"Mechelinck","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhepr.2023.100911_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12968-020-00622-2","article-title":"Myocardial structural and functional changes in patients with liver cirrhosis awaiting liver transplantation: a comprehensive cardiovascular magnetic resonance and echocardiographic study","volume":"22","author":"Kim","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.jhepr.2023.100911_bib39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jjcc.2015.08.001","article-title":"A detailed evaluation of cardiac function in cirrhotic patients and its alteration with or without liver transplantation","volume":"67","author":"Chen","year":"2016","journal-title":"J Cardiol"},{"key":"10.1016\/j.jhepr.2023.100911_bib40","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.jhepr.2023.100911_bib41","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/lt.26460","article-title":"Cirrhotic cardiomyopathy: appraisal of the original and revised criteria in predicting posttransplant cardiac outcomes","volume":"28","author":"Spann","year":"2022","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhepr.2023.100911_bib42","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCHEARTFAILURE.115.002161","article-title":"E\/e\u2019 Ratio in Patients With Unexplained Dyspnea: lack of Accuracy in Estimating Left Ventricular Filling Pressure","volume":"8","author":"Santos","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jhepr.2023.100911_bib43","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"40","author":"Pieske","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jhepr.2023.100911_bib44","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/TP.0b013e31825f0f97","article-title":"Diastolic dysfunction in patients with end-stage liver disease is associated with development of heart failure early after liver transplantation","volume":"94","author":"Dowsley","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2023.100911_bib45","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gut.49.2.268","article-title":"The cardiac response to exercise in cirrhosis","volume":"49","author":"Wong","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100911_bib46","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s12072-014-9531-y","article-title":"Cirrhotic cardiomyopathy: review of pathophysiology and treatment","volume":"8","author":"Chayanupatkul","year":"2014","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2023.100911_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8122132","article-title":"Cardiac imaging in liver transplantation candidates: current knowledge and future perspectives","volume":"8","author":"Dimitroglou","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhepr.2023.100911_bib48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcmg.2019.02.031","article-title":"CMR in the evaluation of diastolic dysfunction and phenotyping of HFpEF: current role and future perspectives","volume":"13","author":"Chamsi-Pasha","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jhepr.2023.100911_bib49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1532-429X-12-59","article-title":"The 20 year evolution of dobutamine stress cardiovascular magnetic resonance","volume":"12","author":"Charoenpanichkit","year":"2010","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jhepr.2023.100911_bib50","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4330\/wjc.v6.i7.585","article-title":"Distribution of late gadolinium enhancement in various types of cardiomyopathies: significance in differential diagnosis, clinical features and prognosis","volume":"6","author":"Satoh","year":"2014","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jhepr.2023.100911_bib51","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.jacc.2009.11.011","article-title":"ACCF\/ACR\/AHA\/NASCI\/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American college of Cardiology foundation task force on expert consensus documents","volume":"55","author":"American College of Cardiology Foundation Task Force on Expert Consensus","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhepr.2023.100911_bib52","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCULATIONAHA.109.930636","article-title":"Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans","volume":"122","author":"Flett","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jhepr.2023.100911_bib53","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009535","article-title":"Myocardial extracellular volume fraction adds prognostic information beyond myocardial replacement fibrosis","volume":"12","author":"Yang","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jhepr.2023.100911_bib54","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/liv.13870","article-title":"Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome","volume":"38","author":"Wiese","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100911_bib55","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.110.007641","article-title":"On T2\u2217 magnetic resonance and cardiac iron","volume":"123","author":"Carpenter","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jhepr.2023.100911_bib56","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1399-0012.2009.01136.x","article-title":"Hepatic and cardiac iron overload among patients with end-stage liver disease referred for liver transplantation","volume":"24","author":"O\u2019Glasser","year":"2010","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jhepr.2023.100911_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.carpath.2018.12.008","article-title":"Cardiac iron overload following liver transplantation in patients without hereditary hemochromatosis or severe hepatic iron deposition","volume":"40","author":"Papadodima","year":"2019","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jhepr.2023.100911_bib58","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/his.12417","article-title":"Iron overload secondary to cirrhosis: a mimic of hereditary haemochromatosis?","volume":"65","author":"Abu Rajab","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.jhepr.2023.100911_bib59","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1097\/TXD.0000000000000803","article-title":"Cardiac MRI T2\u2217 in liver transplant candidates: application and performance of a novel imaging technique to identify patients at risk for poor posttransplant cardiac outcomes","volume":"4","author":"Lewin","year":"2018","journal-title":"Transpl Direct"},{"key":"10.1016\/j.jhepr.2023.100911_bib60","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/lt.24768","article-title":"Cirrhotic cardiomyopathy: implications for liver transplantation","volume":"23","author":"Liu","year":"2017","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhepr.2023.100911_bib61","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/liv.14769","article-title":"The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria","volume":"41","author":"Razpotnik","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100911_bib62","first-page":"s514","article-title":"Cirrhotic cardiomyopathy per 2005 criteria is more common and less reversible than cirrhotic cardiomyopathy per 2019 criteria","volume":"76","author":"Arman","year":"2022","journal-title":"Hepatoloty"},{"key":"10.1016\/j.jhepr.2023.100911_bib63","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/hep.31463","article-title":"Correction","volume":"72","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100911_bib64","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1002\/hep.32021","article-title":"Diagnostic criteria of cirrhotic cardiomyopathy: out with the old, in with the new?","volume":"74","author":"Liu","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100911_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270784","article-title":"Chronotropic incompetence in end-stage liver disease","volume":"17","author":"Glowczynska","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2023.100911_bib66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1540-8167.2006.00622.x","article-title":"QT interval correction in patients with cirrhosis","volume":"18","author":"Zambruni","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jhepr.2023.100911_bib67","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/hep.510270106","article-title":"Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors","volume":"27","author":"Bernardi","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100911_bib68","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/00365510601182634","article-title":"Q-T interval (QT(C)) in patients with cirrhosis: relation to vasoactive peptides and heart rate","volume":"67","author":"Henriksen","year":"2007","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jhepr.2023.100911_bib69","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4291\/wjgp.v9.i1.28","article-title":"Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity","volume":"9","author":"Tsiompanidis","year":"2018","journal-title":"World J Gastrointest Pathophysiol"},{"key":"10.1016\/j.jhepr.2023.100911_bib70","first-page":"G537","article-title":"Potassium currents in atrial and ventricular myocytes from a rat model of cirrhosis","volume":"273","author":"Ward","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhepr.2023.100911_bib71","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4330\/wjc.v9.i4.347","article-title":"QT prolongation is associated with increased mortality in end stage liver disease","volume":"9","author":"Kim","year":"2017","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jhepr.2023.100911_bib72","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/00365521.2021.1901307","article-title":"Prolonged QTc interval predicts long-term mortality in cirrhosis: a propensity score matching analysis","volume":"56","author":"Li","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100911_bib73","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/hep.26509","article-title":"Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine","volume":"58","author":"Ruiz-del-Arbol","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100911_bib74","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100911_bib75","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100911_bib76","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/ajg.2009.321","article-title":"The use of E\/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt","volume":"104","author":"Rabie","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100911_bib77","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/gut.2006.102467","article-title":"Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt","volume":"56","author":"Cazzaniga","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100911_bib78","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jhep.2019.10.002","article-title":"Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation","volume":"72","author":"Giannelli","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100911_bib79","doi-asserted-by":"crossref","first-page":"91","DOI":"10.31083\/j.rcm2303091","article-title":"Cardiovascular events after liver transplantation: MACE hurts","volume":"23","author":"Altieri","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.jhepr.2023.100911_bib80","series-title":"Cardio-hepatology: connections between hepatic and cardiovascular diseases","first-page":"327","article-title":"Predicting cardiovascular complications after liver transplantation","author":"Gurram","year":"2022"},{"key":"10.1016\/j.jhepr.2023.100911_bib81","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/FJC.0000000000000872","article-title":"Protective effects of spermidine against cirrhotic cardiomyopathy in bile duct-ligated rats","volume":"76","author":"Sheibani","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jhepr.2023.100911_bib82","doi-asserted-by":"crossref","first-page":"120966","DOI":"10.1016\/j.lfs.2022.120966","article-title":"Evaluation of statins as a new therapy to alleviate chronotropic dysfunction in cirrhotic rats","volume":"308","author":"Niaz","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.jhepr.2023.100911_bib83","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.26021","article-title":"Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms","volume":"57","author":"Bortoluzzi","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100911_bib84","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5114\/ceh.2020.99513","article-title":"Taurine mitigates cirrhosis-associated heart injury through mitochondrial-dependent and antioxidative mechanisms","volume":"6","author":"Mousavi","year":"2020","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.jhepr.2023.100911_bib85","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s12265-020-09997-0","article-title":"Exercise training attenuates cirrhotic cardiomyopathy","volume":"14","author":"de Souza","year":"2021","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.jhepr.2023.100911_bib86","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.26127","article-title":"Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction","volume":"57","author":"La Mura","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100911_bib87","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/gutjnl-2014-308338","article-title":"KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins","volume":"64","author":"Marrone","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100911_bib88","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jhep.2018.07.019","article-title":"Statins: old drugs as new therapy for liver diseases?","volume":"70","author":"Pose","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100911_bib89","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/thx.2005.057976","article-title":"Potential therapeutic role for statins in respiratory disease","volume":"61","author":"Hothersall","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.jhepr.2023.100911_bib90","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jhep.2010.03.011","article-title":"Mechanisms of TNFalpha-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNFalpha and endocannabinoids","volume":"53","author":"Yang","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100911_bib91","article-title":"Albumin therapy for hepatic encephalopathy: current evidence and controversies","author":"Wong","year":"2022","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jhepr.2023.100911_bib92","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hep.28890","article-title":"Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart","volume":"65","author":"Desai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100911_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.108972","article-title":"Taurine protects against cardiac dysfunction induced by pressure overload through SIRT1-p53 activation","volume":"317","author":"Liu","year":"2020","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jhepr.2023.100911_bib94","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1042\/CS20130642","article-title":"Cardiomyocyte apoptosis contributes to pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated mice","volume":"127","author":"Nam","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jhepr.2023.100911_bib95","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1053\/jhep.2003.50369","article-title":"Left ventricular hypertrophy in rats with biliary cirrhosis","volume":"38","author":"Inserte","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100911_bib96","first-page":"367","article-title":"Silymarin administration attenuates cirrhotic-induced cardiac abnormality in the rats: a possible role of beta1-adrenergic receptors and L-type voltage-dependent calcium channels","volume":"47","author":"Bayat","year":"2022","journal-title":"Iran J Med Sci"},{"key":"10.1016\/j.jhepr.2023.100911_bib97","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cyto.2011.06.001","article-title":"Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function","volume":"55","author":"Wanninger","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.jhepr.2023.100911_bib98","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/eurjhf\/hfq091","article-title":"Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure","volume":"12","author":"Shah","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jhepr.2023.100911_bib99","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1161\/CIRCHEARTFAILURE.112.000146","article-title":"Galectin-3 and cardiac function in survivors of acute myocardial infarction","volume":"6","author":"Weir","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jhepr.2023.100911_bib100","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jacc.2006.03.061","article-title":"Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure","volume":"48","author":"van Kimmenade","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jhepr.2023.100911_bib101","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jhepr.2023.100911_bib102","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ajpath.2017.01.016","article-title":"Association of cardiac galectin-3 expression, myocarditis, and fibrosis in chronic chagas disease cardiomyopathy","volume":"187","author":"Souza","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhepr.2023.100911_bib103","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","article-title":"Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis","volume":"6","author":"Yu","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jhepr.2023.100911_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.961414","article-title":"Effects of high-intensity and moderate-intensity exercise training on cardiopulmonary function in patients with coronary artery disease: a meta-analysis","volume":"9","author":"Zheng","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jhepr.2023.100911_bib105","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/apt.16305","article-title":"Review article: comprehensive analysis of cirrhotic cardiomyopathy","volume":"53","author":"Chahal","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2023.100911_bib106","first-page":"11","article-title":"What\u2019s new in cirrhotic cardiomyopathy?-review article","author":"Bodys-Pelka","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.jhepr.2023.100911_bib107","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3350\/cmh.2020.0234","article-title":"beta-blockers in advanced cirrhosis: more friend than enemy","volume":"27","author":"Yoon","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100911_bib108","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/MEG.0000000000001128","article-title":"beta-Blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial","volume":"30","author":"Silvestre","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100911_bib109","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2020.03.048","article-title":"Short-term hemodynamic effects of beta-blockers influence survival of patients with decompensated cirrhosis","volume":"73","author":"Alvarado-Tapias","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100911_bib110","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gutjnl-2011-301348","article-title":"The window hypothesis: haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease","volume":"61","author":"Krag","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2023.100911_bib111","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10741-019-09774-5","article-title":"Effects of exercise training on cardiac function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials","volume":"24","author":"Fukuta","year":"2019","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jhepr.2023.100911_bib112","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.2012.8720","article-title":"Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial","volume":"308","author":"Blumenthal","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jhepr.2023.100911_bib113","article-title":"Cardiac health in patients with hepatitis B virus-related cirrhosis","volume":"98","author":"Yuan","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhepr.2023.100911_bib114","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2015.10.018","article-title":"Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure","volume":"64","author":"Mookerjee","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100911_bib115","doi-asserted-by":"crossref","first-page":"849","DOI":"10.5009\/gnl210537","article-title":"Prolonged QT interval in cirrhosis: twisting time?","volume":"16","author":"Lee","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.jhepr.2023.100911_bib116","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/CIRCULATIONAHA.118.033943","article-title":"Determination and interpretation of the QT interval","volume":"138","author":"Vink","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jhepr.2023.100911_bib117","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jhep.2022.12.005","article-title":"Beta-blockers in the era of precision medicine in patients with cirrhosis","volume":"78","author":"Albillos","year":"2023","journal-title":"J\u00a0Hepatol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923002422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923002422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T05:59:06Z","timestamp":1716271146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923002422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":117,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2589555923002422"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100911","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiomyopathy in cirrhosis: From pathophysiology to clinical care","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100911"}}